GP Prescribing a good standard but improvement possible

(Medical Xpress) -- A major study of GP prescribing, led by The University of Nottingham, has found that while the vast majority of prescriptions written by family doctors are appropriate and effectively monitored, around 1 in 20 contain an error.

Researchers looking at a sample of GP practices in England found that where there were errors, most were classed as mild or moderate, but around one in every 550 prescription items was judged to contain a serious error. The most common errors were missing information on dosage, prescribing an incorrect dosage, and failing to ensure that patients got necessary monitoring through blood tests.

The research, commissioned by the General Medical Council, is the largest-scale study of its kind. It provides an important insight into how errors in prescribing come about and the researchers say improvements can be made to reduce the error rate.

The research recommends a greater role for pharmacists in supporting GPs, better use of computer systems and extra emphasis on prescribing in GP training.

Professor Tony Avery of The University of Nottingham’s medical school, who led the research, said:

“Few were associated with significant risks to patients but it’s important that we do everything we can to avoid all errors. GPs must ensure they have ongoing training in prescribing, and practices should ensure they have safe and effective systems in place for repeat prescribing and monitoring. I’d also encourage doctors to share their experiences of prescribing issues both informally within their practices, and also formally where appropriate through local or national reporting systems. Prescribing is a skill, and it is one that all doctors should take time to develop and keep up-to-date.”

Professor Sir Peter Rubin, Chair of the General Medical Council, said: “GPs are typically very busy, so we have to ensure they can give prescribing the priority it needs. Using effective computer systems to ensure potential errors are flagged and patients are monitored correctly is a very important way to minimise errors. Doctors and patients could also benefit from greater involvement from pharmacists in supporting prescribing and monitoring. We will be leading discussions with relevant organisations, including the RCGP, the CQC and the Chief in the Department of Health, to ensure that our findings are translated into actions that help protect patients.”

add to favorites email to friend print save as pdf

Related Stories

Physicians click their way to better prescriptions

Mar 10, 2010

Is it time for all community-based doctors to turn to e-prescribing to cut down on the number of medication errors? According to Rainu Kaushal and colleagues from the Weill Cornell Medical College in New York, electronic ...

Recommended for you

Boxed warnings are common in novel therapeutics

Aug 19, 2014

(HealthDay)—Boxed warnings are common on recent drug approvals, and many occur years after approval, according to a research letter published online Aug. 15 in JAMA Internal Medicine.

AstraZeneca says DOJ closes probe into drug trial

Aug 19, 2014

British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action.

Perampanel for epilepsy: Still no proof of added benefit

Aug 19, 2014

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In a new early benefit assessment ...

User comments